1 September 2022
CAMELLIA PLC INTERIM RESULTS Camellia Plc (AIM:CAM) announces its interim results for the six months ended 30 June 2022. Malcolm Perkins,…
31 August 2022
Half-year Report – six months ended 30 June 2022…
Sale of non-core petrol forecourt business enables Co-op to focus on core convenience proposition whilst significantly deleveraging and strengthening the Group's balance sheet…
Disposal of interests in Agricultural Supplies Division with a streamlined focus on being an international leader in manufacturing value added products and solutions in Speciality Agriculture and Engineering…
30 August 2022
Farxiga significantly reduced the risk of cardiovascular death or worsening of heart failure in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial…
25 August 2022
Tagrisso approved in Japan for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer…
Lynparza approved in Japan as adjuvant treatment for patients with BRCA-mutated HER2-negative high-risk early breast cancer…
24 August 2022
Condensed half-yearly financial report 30 June 2022…